Formal national pathway
National Registration
Review the classification, evidence, documentation, responsible-party, and current-rule questions that shape NMPA registration or filing.
Pathway context
What this route can—and cannot—address.
The formal NMPA route for products seeking the applicable Mainland China registration or filing and a basis for broader commercialization within the resulting permitted scope.
Boundary. Requirements depend on product classification, evidence, documentation, quality systems, and current rules. Review remains with the relevant authorities, and no approval is guaranteed.
Last reviewed: 2 August 2026
- Geographic scope
- Mainland China within the scope of the resulting registration, filing, and other applicable permissions.
- Eligibility context
- A filing or registration submission that meets the current requirements for the product’s category and classification.
- Primary use case
- The formal national route for product registration or filing and subsequent activities within the permitted scope.
- Institution requirement
- Institutional or clinical participation depends on the product and evidence plan; a hospital is not the general substitute for the applicant and responsible-party requirements.
- Evidence limitations
- The evidence package must meet the applicable NMPA technical, clinical, quality, and documentary requirements.
- Commercial boundary
- Commercial activity remains subject to the registered or filed scope and other applicable market-access, distribution, procurement, and compliance requirements.
- Relationship to national registration
- This is the formal national route, not a regional special-access mechanism.
Primary material